4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Lung Adenocarcinoma

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Lung Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Agostino, J; Ding, X; Xie, F; Zhou, X	1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Lung Adenocarcinoma

Article	Year
Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Female; Lung; Lung Neoplasms; Mice; Mice, Knockout; Microsomes, Liver; Nitrosamines; Pyridines; Tissue Distribution	2012

Article

Year

Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.

The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Female; Lung; Lung Neoplasms; Mice; Mice, Knockout; Microsomes, Liver; Nitrosamines; Pyridines; Tissue Distribution

2012